cerca CERCA
Martedì 19 Ottobre 2021
Aggiornato: 20:48
Temi caldi

leading biotech company active

Inbiose applies for FDA GRAS approval of four new Human Milk Oligosaccharides

GHENT, Belgium, July 6, 2021 /PRNewswire/ -- Inbiose, a leading biotech company active in the development of Human Milk Oligosaccharides (HMOs), is pleased to announce that it has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs, specifically 6'-Sialyllactose (6'SL), 3-Sialyllactose (3'SL), Lacto-N-Tetraose (LNT) and Lacto-N-neoTetraose (LNnT). Inbiose will also file for Novel Food approval of these HMOs by the Eu...

ora in
Prima pagina
in Evidenza